[51] found in nasopharyngeal carcinoma, ISG15 interacts with its receptor LFA-1 to polarize tumor-associated macrophages (TAMs) to the M2 phenotype, inhibit the effector function of CD8 + T cells, and thus engender an immunosuppressive microenvironment. Here, ISG15 is linked to neoplasm.